menu
    • menu

    Company profile for Eyenuk

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see ...
    Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father’s struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EyenukUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5850 Canoga Avenue, Ste. 250 Woodland Hills, CA 91367, USA
    Telephone
    Telephone
    + (1) 818 835 3585
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eyenuk.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eyenuk-llc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/EyenukInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eyenuk Welcomes Paul Praino as Chief Commercial Officer
    Eyenuk Welcomes Paul Praino as Chief Commercial Officer

    16 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/16/2609682/0/en/Eyenuk-Welcomes-Paul-Praino-as-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    16 Feb 2023
    Share Share
    Eyenuk Secures the First EU Union MDR Certification for Autonomous AI Detection
    Eyenuk Secures the First EU Union MDR Certification for Autonomous AI Detection

    31 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/31/2598236/0/en/Eyenuk-Secures-the-First-European-Union-MDR-Certification-for-Autonomous-AI-Detection-of-Diabetic-Retinopathy-Age-Related-Macular-Degeneration-and-Glaucoma.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share
    Eyenuk hits bull's-eye with $26M for diabetic retinopathy screening AI
    Eyenuk hits bull's-eye with $26M for diabetic retinopathy screening AI

    17 Oct 2022

    // Andrea Park FIERCEBIOTECH

    https://www.fiercebiotech.com/medtech/eyenuk-hits-bulls-eye-26m-diabetic-retinopathy-screening-ai

    Andrea Park FIERCEBIOTECH
    17 Oct 2022
    Share Share
    Eyenuk's EyeArt is the Only Diabetic Eye Screening AI Technology
    Eyenuk's EyeArt is the Only Diabetic Eye Screening AI Technology

    01 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/01/2453853/0/en/UK-National-Screening-Committee-Report-Singles-Out-Eyenuk-s-EyeArt-as-the-Only-Diabetic-Eye-Screening-AI-Technology-Ready-for-Live-Clinical-Implementation-in-the-National-Health-Se.html

    GLOBENEWSWIRE
    01 Jun 2022
    Share Share
    Eyenuk Joins the Population Health Alliance
    Eyenuk Joins the Population Health Alliance

    10 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/10/2400880/0/en/Eyenuk-Joins-the-Population-Health-Alliance-Paving-Way-for-Autonomous-AI-to-Improve-Diabetes-Complications.html

    GLOBENEWSWIRE
    10 Mar 2022
    Share Share
    Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results
    Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results

    15 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/15/2334632/0/en/Eyenuk-Announces-Publication-of-Strong-EyeArt-Pivotal-Clinical-Trial-Results-in-JAMA-Network-Open.html

    GLOBENEWSWIRE
    15 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search